Patents by Inventor Flavio OSSOLA

Flavio OSSOLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Beta-lactamase inhibitors
    Patent number: 10597396
    Abstract: This invention pertains generally to compounds of Formula (A), as further described herein, which act as beta-lactamase inhibitors, and salts, crystalline forms and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds in combination with a beta-lactam antibiotic to treat infections caused by Gram-negative bacteria, including drug-resistant strains.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: March 24, 2020
    Assignee: Novartis AG
    Inventors: Anthony Casarez, Markus Furegati, Guido Koch, Xiaodong Lin, Flavio Ossola, Folkert Reck, Robert Lowell Simmons, Qingming Zhu
  • BETA-LACTAMASE INHIBITORS
    Publication number: 20190177324
    Abstract: This invention pertains generally to compounds of Formula (A), as further described herein, which act as beta-lactamase inhibitors, and salts, crystalline forms and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds in combination with a beta-lactam antibiotic to treat infections caused by Gram-negative bacteria, including drug-resistant strains.
    Type: Application
    Filed: September 28, 2017
    Publication date: June 13, 2019
    Applicant: Novartis AG
    Inventors: Anthony CASAREZ, Markus FUREGATI, Guido KOCH, Xiaodong LIN, Flavio OSSOLA, Folkert RECK, Robert Lowell SIMMONS, Qingming ZHU
  • Beta-lactamase inhibitors
    Patent number: 10065957
    Abstract: This invention pertains generally to compounds of Formula (A), as further described herein, which act as beta-lactamase inhibitors, and salts, crystalline forms and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds in combination with a beta-lactam antibiotic to treat infections caused by Gram-negative bacteria, including drug-resistant strains.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: September 4, 2018
    Assignee: Novartis AG
    Inventors: Anthony Casarez, Markus Furegati, Guido Koch, Xiaodong Lin, Flavio Ossola, Folkert Reck, Robert Lowell Simmons, Qingming Zhu
  • BETA-LACTAMASE INHIBITORS
    Publication number: 20180086762
    Abstract: This invention pertains generally to compounds of Formula (A), as further described herein, which act as beta-lactamase inhibitors, and salts, crystalline forms and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds in combination with a beta-lactam antibiotic to treat infections caused by Gram-negative bacteria, including drug-resistant strains.
    Type: Application
    Filed: September 28, 2017
    Publication date: March 29, 2018
    Inventors: Anthony CASAREZ, Markus FUREGATI, Guido KOCH, Xiaodong LIN, Flavio OSSOLA, Folkert RECK, Robert Lowell SIMMONS, Qingming ZHU